All sponsors

Deciphera Pharmaceuticals, LLC

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS7
PHASE 3 / 2-33
RECRUITING2
READOUTS ≤12 MONTHS1
READOUT SLIPPED >6 MO29%

Delay Index: of 7 active trials registered more than a year ago, 2 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →

Open Deciphera Pharmaceuticals, LLC on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
INTRIGUE
NCT03673501
P3Active, not recruitingGastrointestinal Stromal Tumors4532021-09-01 (+3 mo)
MOTION
NCT05059262
P3Active, not recruitingTenosynovial Giant Cell Tumor; Pigmented Villonodular Synovitis1232023-08-10 (-7 mo)
Inlexisertib
NCT05957367
P1/2Active, not recruitingGIST942027-03
INSIGHT
NCT05734105
P3Active, not recruitingGIST542027-12 (+22 mo)
DCC-3009
NCT06630234
P1/2RecruitingGastrointestinal Stromal Tumor (GIST)1552028-05
Vimseltinib
NCT03069469
P1/2Active, not recruitingAdvanced Malignant Neoplasm; Pigmented Villonodular Synovitis1202028-08 (+120 mo)
Vimseltinib
NCT06619561
P2RecruitingChronic Graft-Versus-Host Disease (cGVHD)482029-10